In the latest episode of the ERJ podcast, Deputy Chief Editor Don Sin interviews Steven D. Nathan about the PERFECT study, which showed that inhaled treprostinil does not demonstrate a positive risk–benefit ratio in favour of treatment in pulmonary hypertension (PH) associated with COPD.
Listen now
Tuesday, 9 July 2024
ERJ podcast: inhaled treprostinil in PH associated with COPD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment